FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carrie Lee

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Thomas E Stinchcombe; Mark Taylor; Kamal Bakri; Jennifer L Beaumont; Daniel S Bradford; Jeffrey M Crane; Harry D Harper; Thomas A Hensing; Carrie B Lee; Edwin McElroy; Dominic T Moore; Harvey B Niell; Sridhar Pal; Amy Peterman; Garry Schwartz; Mark A Socinski
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.
Matthew D Wilkerson; Xiaoying Yin; Katherine A Hoadley; Yufeng Liu; Michele C Hayward; Christopher R Cabanski; Kenneth Muldrew; Ryan Miller; Scott H Randell; Mark A Socinski; Alden M Parsons; William K Funkhouser; Carrie B Lee; Patrick J Roberts; Leigh B Thorne; Philip S Bernard; Charles M Perou; David Hayes
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.
Carrie B Lee; Thomas E Stinchcombe; Dominic T Moore; David E Morris; David Hayes; Jan S Halle; Julian G Rosenman; Maria Rivera; Mark A Socinski
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carrie Lee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Thomas E Stinchcombe; Mark Taylor; Kamal Bakri; Jennifer L Beaumont; Daniel S Bradford; Jeffrey M Crane; Harry D Harper; Thomas A Hensing; Carrie B Lee; Edwin McElroy; Dominic T Moore; Harvey B Niell; Sridhar Pal; Amy Peterman; Garry Schwartz; Mark A Socinski
A randomized phase II trial of first-line treatment with gemcitabine, erlotinib, or gemcitabine and erlotinib in elderly patients (age ≥70 years) with stage IIIB/IV non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1569-77.
2010: Matthew D Wilkerson; Xiaoying Yin; Katherine A Hoadley; Yufeng Liu; Michele C Hayward; Christopher R Cabanski; Kenneth Muldrew; Ryan Miller; Scott H Randell; Mark A Socinski; Alden M Parsons; William K Funkhouser; Carrie B Lee; Patrick J Roberts; Leigh B Thorne; Philip S Bernard; Charles M Perou; David Hayes
Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(19):4864-75.
2009: Carrie B Lee; Thomas E Stinchcombe; Dominic T Moore; David E Morris; David Hayes; Jan S Halle; Julian G Rosenman; Maria Rivera; Mark A Socinski
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(1):74-9.
2008: Thomas E Stinchcombe; Carrie B Lee; Dominic T Moore; Maria Rivera; Jan S Halle; Steven A Limentani; Julian G Rosenman; Mark A Socinski
Long-term follow-up of a phase I/II trial of dose escalating three-dimensional conformal thoracic radiation therapy with induction and concurrent carboplatin and paclitaxel in unresectable stage IIIA/B non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(11):1279-85.
2008: Thomas E Stinchcombe; Mark A Socinski; Carrie B Lee; David Hayes; Dominic T Moore; Richard M Goldberg; Elizabeth Dees
Phase I trial of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with thoracic malignancies.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):521-6.
2008: Thomas E Stinchcombe; David E Morris; Carrie B Lee; Dominic T Moore; David Hayes; Jan S Halle; Maria Rivera; Julian G Rosenman; Mark A Socinski
Induction chemotherapy with carboplatin, irinotecan, and paclitaxel followed by high dose three-dimension conformal thoracic radiotherapy (74 Gy) with concurrent carboplatin, paclitaxel, and gefitinib in unresectable stage IIIA and stage IIIB non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(3):250-7.
2007: Carrie B Lee; Mark A Socinski
Vascular endothelial growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer: a review of recent clinical trials.
Reviews on recent clinical trials 2007;2(2):117-20.
2006: Carrie B Lee; Thomas E Stinchcombe; Julian G Rosenman; Mark A Socinski
Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: evolving role of dose-escalated conformal (3-dimensional) radiation therapy.
Clinical lung cancer 2006;8(3):195-202.
2006: Thomas E Stinchcombe; Carrie B Lee; Mark A Socinski
Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status.
Clinical lung cancer 2006;7 Suppl 4():S111-7.
2006: Carrie B Lee; David E Morris; Daniel B Fried; Mark A Socinski
Current and evolving treatment options for limited stage small cell lung cancer.
Current opinion in oncology 2006;18(2):162-72.